Five Prime Therapeutics, Inc. FPRX
$ 38.0
0.0%
Five Prime Therapeutics, Inc. Balance Sheet 2011-2024 | FPRX
Annual Balance Sheet Five Prime Therapeutics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-22 M | -6.19 M | -44 M | -59.8 M | -7.65 M | -150 M | -15.3 M | -8.16 M | -11.4 M | -4.36 M |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
44.4 M | 50.6 M | 28.9 M | 27.9 M | 18 M | 35.7 M | 50.6 M | 9.94 M | 147 M | 136 M |
Total Current Liabilities |
22.2 M | 23 M | 27.5 M | 51 M | 38.7 M | 79.4 M | 19.8 M | 13.8 M | 13.1 M | 12.7 M |
Total Liabilities |
66.6 M | 73.7 M | 56.4 M | 78.8 M | 56.7 M | 115 M | 70.4 M | 23.8 M | 160 M | 149 M |
Deferred Revenue |
- | 1.3 M | 1.43 M | 12.7 M | 14.2 M | 17.5 M | 11.9 M | 7.91 M | 7.5 M | 4 M |
Retained Earnings |
-516 M | -432 M | -295 M | -156 M | -5.05 M | 60.6 M | -189 M | -152 M | -123 M | -95.1 M |
Total Assets |
332 M | 224 M | 322 M | 344 M | 448 M | 548 M | 156 M | 81.8 M | 44.1 M | 58.6 M |
All numbers in USD currency